References
- World Health Organization (WHO). The top 10 causes of death; 2018 [ cited 2020 Apr 23]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
- Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010 a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2197–2223.
- Freedman B, Potpara TS, Lip GY. Stroke prevention in atrial fibrillation. Lancet. 2016;388(10046):806–817.
- Johnson CO, Nguyen M, Roth GA, GBD. stroke collaborators. global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):439–458.
- Fuster V, Ryden LE, Cannom DS, et al. ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2011;123(10):e269–367.
- Boriani G, Laroche C, Diemberger I, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF pilot general registry. Am J Med. 2015;128(5):509–18.e2.
- Hannon N, Sheehan O, Kelly L, et al. Stroke associated with atrial fibrillation–incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis. 2010;29(1):43–49.
- Andrew NE, Thrift AG, Cadilhac DA. The prevalence, impact and economic implications of atrial fibrillation in stroke: what progress has been made? Neuroepidemiology. 2013;40(4):227–239.
- Jørgensen HS, Nakayama H, Reith J, et al. Acute stroke with atrial fibrillation. The Copenhagen stroke study. Stroke. 1996;27(10):1765–1769.
- Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005;36(6):1115–1119.
- Ministry of Health. Scientific Group for Cardiovascular Diseases. Therapeutic Protocol for anticoagulation treatment in atrial fibrillation patients; 2018 [ cited 2020 Apr 12]. Available from: https://www.moh.gov.gr/articles/health/domes-kai-draseis-gia-thn-ygeia/kwdikopoihseis/therapeytika-prwtokolla-syntagografhshs/diagnwstika-kai-therapeytika-prwtokolla-syntagografhshs/5417-diagnwstika-kai-therapeytika-prwtokolla-syntagografhshs-kardiaggeiakwn-noshmatwn
- OECD/European Observatory on Health Systems and Policies (2019), Greece: country Health Profile 2019, State of Health in the EU, OECD Publishing, Paris [ cited 2020 Apr 12]. Available from: https://doi.org/10.1787/d87da56a-en
- Bruggenjurgen B, Rossnagel K, Roll S, et al., The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study. Value Health. 2007;10(2): 137–143.
- Ghatnekar O, Glader EL. The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001. Value Health. 2008;11(5):862–868.
- Vemmos KN, Bots ML, Tsibouris PK, et al. Prognosis of stroke in the south of Greece: 1 year mortality, functional outcome and its determinants: the Arcadia stroke registry. J Neurol Neurosurg Psychiatr. 2000;69(5):595–600.
- Tsivgoulis G, Patousi A, Pikilidou M, et al. Stroke incidence and outcomes in Northeastern Greece: the evros stroke registry. Stroke. 2018;49(2):288–295.
- Diener H-C, Ntaios G, O’Donnell M, et al. Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke. Expert Opin Pharmacother. 2018;19(14):1597–1602.
- Ntaios G, Papavasileiou V, Diener HC, et al. Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials. Stroke. 2012;43(12):3298–3304.
- Fattore G, Torbica A, Susi A, et al., The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study. BMC Neurol. 2012;12(1): 137.
- Ministry of Health. Diagnostic related groups; 2012 [ cited 2019 Nov 20]. Available from: http://www.moh.gov.gr/articles/health/domes-kai-draseis-gia-thn-ygeia/kwdikopoihseis/709-kleista-enopoihmena-noshlia-1
- National Organization for the Provision of Healthcare Services (EOPYY). Medical procedures. [ cited 2019 Nov 20]. Available from https://eopyyfiles.blob.core.windows.net/eopyysite/ServiceCategories/c569d857-4952-40b5-b435-452178ecfdec.pdf
- Government Gazette 4898/B/1-11-2018 [ cited 2019 Nov 20]. Available from: https://www.ispatras.gr/wp-content/uploads/2018/11/%CE%95%CE%9A%CE%A0%CE%A5-%CE%95%CE%9F%CE%A0%CE%A5%CE%A5-%CE%95%CE%91%CE%9B%CE%95%CE%93.%CE%A0.801572018-%CE%A6%CE%95%CE%9A-4898_%CF%84%CE%92_1-11-2018-1.pdf
- Ministry of Health. Positive price list August 2018 [ cited 2019 Nov 30]. Available from: https://www.moh.gov.gr/articles/times-farmakwn/thetikh-lista
- Maniadakis N, Kaitelidou D, Siskou O, et al. Economic evaluation of treatment strategies for patients suffering acute myocardial infarction in Greece. Hellenic J Cardiol. 2005;46(3):212–221.
- Government Gazette 2883/B/ 26- 10-2012 [ cited 2019 Nov 30]. Available from: https://www.eof.gr/assets/FEK_2883.pdf
- Hellenic Statistical Authority. Unemployment rate January 2018 [ cited 2019 Oct 10]. Available from: https://www.statistics.gr/el/statistics/-/publication/SJO02/2018-M01
- PHC WE, Sunnerhagen Katharina S, Sunnerhagen KS. Return to work after a stroke in working age persons; A six-year follow up. PloS One. 2017;12(1):e0169759.
- Kritikou P, Spengos K, Zakopoulos N, et al. Resource utilization and costs for treatment of stroke patients in an acute stroke unit in Greece. Clin Neurol Neurosurg. 2016;142:8–14.
- OECD Statistics. Average annual wages [ cited 2019 Oct 23]. Available from: https://stats.oecd.org/Index.aspx?DataSetCode=AV_AN_WAGE
- Hellenic Stroke Organization. Official website [ cited 2020 Apr 23]. Available from: https://www.stroke.gr/en
- Rienstra M, Lubitz SA, Mahida S, et al. Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation. 2012;125(23):2933–2943.
- Brandes A, Smit MD, Nguyen BO, et al. Risk factor management in atrial fibrillation. Arrhythm Electrophysiol Rev. 2018;7(2):118–127.
- Wilkins E, Wilson L, Wickramasinghe K, et al. European cardiovascular disease statistics 2017. European Heart Network, Brussels; 2017 [ cited 2019 Aug 20]. Available from: http://www.ehnheart.org/images/CVD-statistics-report-August-2017.pdf
- Martin AL, Reeves AG, Berger SE, et al., Systematic review of societal costs associated with stroke, bleeding and monitoring in atrial fibrillation. J Comp Eff Res. 2019;8(14): 1147–1166.
- OECD. OECD Labour Force Statistics 2019, OECD Publishing, Paris; [ cited 2020 Oct 15]. Available from: https://doi.org/https://doi.org/10.1787/g2g9fb3e-en
- Zoni-Berisso M, Lercari F, Carazza T, et al. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213–220.
- Biosense Webster EMEA. The burden of atrial fibrillation: understanding the impact of the new millennium epidemic across Europe; 2018 [cited 2019 Sep 12]. Available from: https://www.jnjmedicaldevices.com/sites/default/files/user_uploaded_assets/pdf_assets/2018-11/AF_Full_Report_DIGITAL_095102-2509.pdf
- Carter P, Anderson M, Mossialos E. Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective. Eur Heart J. 2020;41(27):2516–2518.
- Law 4675/2020. Government Gazette 54/Α/11-3-2020 [ cited 2020 May 15]. Available from: https://www.taxheaven.gr/law/4675/2020